Carroll Financial Associates’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$17K Sell
143
-23
-14% -$2.55K ﹤0.01% 1012
2021
Q3
$19K Buy
166
+22
+15% +$2.33K ﹤0.01% 1006
2021
Q2
$13K Sell
144
-88
-38% -$7.64K ﹤0.01% 1202
2021
Q1
$17K Hold
232
﹤0.01% 1071
2020
Q4
$15K Sell
232
-3
-1% -$196 ﹤0.01% 992
2020
Q3
$13K Buy
235
+103
+78% +$5.42K ﹤0.01% 970
2020
Q2
$5K Hold
132
﹤0.01% 1179
2020
Q1
$7K Hold
132
﹤0.01% 1023
2019
Q4
$8K Hold
132
﹤0.01% 1119
2019
Q3
$7K Hold
132
﹤0.01% 1095
2019
Q2
$7K Hold
132
﹤0.01% 1091
2019
Q1
$6K Hold
132
﹤0.01% 1059
2018
Q4
$7K Hold
132
﹤0.01% 937
2018
Q3
$7K Hold
132
﹤0.01% 977
2018
Q2
$7K Buy
+132
New +$7.88K ﹤0.01% 926
2016
Q4
Sell
-15
Closed 1133
2016
Q3
$0 Hold
15
﹤0.01% 1139
2016
Q2
$0 Hold
15
﹤0.01% 1130
2016
Q1
$0 Buy
+15
New +$429 ﹤0.01% 1118

Other funds holding AMN

Carroll Financial Associates's AMN Position: Q4 2021 in Review

Carroll Financial Associates reduced its AMN Healthcare (AMN) stake by 14% in Q4 2021, selling an estimated $2.55K and leaving 143 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Carroll Financial Associates first reported a position in AMN in Q1 2016 and has held it in 18 quarters since. The position peaked at $19K in Q3 2021. 409 funds tracked by Wall St. Rank hold AMN as of Q4 2021.

  • Carroll Financial Associates held 143 shares of AMN Healthcare worth $17K as of Q4 2021.
  • Carroll Financial Associates sold 23 AMN Healthcare shares in Q4 2021, an estimated $2.55K.
  • AMN Healthcare made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1012 holding.
  • Carroll Financial Associates first reported a position in AMN Healthcare in Q1 2016 and has held it in 18 quarters since.
  • Carroll Financial Associates's AMN Healthcare position peaked at $19K in Q3 2021.
  • 409 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.